PubRank

C Yoshikumi

Author PubWeight™ 8.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A biological response modifier, PSK, inhibits reverse transcriptase in vitro. Biochem Biophys Res Commun 1987 1.06
2 Specific expression of HSP27 in human tumor cell lines in vitro. In Vivo 1997 0.85
3 The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice. Anticancer Res 1987 0.81
4 Restoration of antibody-forming capacities by PS-K in tumor-bearing mice. Gan 1975 0.79
5 Effect of PSK, a protein-bound polysaccharide from Coriolus versicolor, on drug-metabolizing enzymes in sarcoma-180 bearing and normal mice. Int J Immunopharmacol 1988 0.79
6 Specific expression of HSP47 in human tumor cell lines in vitro. In Vivo 1997 0.79
7 Mouse strain difference in the expression of antitumor activity of PS-K. Gan 1975 0.78
8 Enhancement of the antitumor effect by the concurrent use of a monoclonal antibody and the protein-bound polysaccharide PSK in mice bearing a human cancer cell line. In Vivo 1994 0.76
9 Decreased expression of HSP47 in highly malignant mouse fibrosarcoma. In Vivo 1996 0.76
10 Specific regulation of HSPs in human tumor cell lines by flavonoids. In Vivo 1997 0.76
11 Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts. J Clin Lab Immunol 1990 0.76
12 [Competitive effect of PSK against the immunosuppressive effect induced in the sera of mice bearing syngeneic tumors]. Gan To Kagaku Ryoho 1986 0.75
13 Influence of PSK (Krestin) on resistance to infection of Pseudomonas aeruginosa in tumor-bearing mice. Cancer Chemother Pharmacol 1987 0.75
14 Effect of a biological response modifier, PSK, on intestinal flora of tumor-bearing mice. In Vivo 1993 0.75
15 Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice. Anticancer Res 1987 0.75
16 [Effect of PSK on the recovery of macrophage function in tumor-bearing mice]. Gan To Kagaku Ryoho 1984 0.75
17 Effect of PSK on prohibited immunity of splenectomized mice. Anticancer Res 1987 0.75
18 Restoration of immune responsiveness by a biological response modifier, PSK, in aged mice bearing syngeneic transplantable tumor. J Clin Lab Immunol 1987 0.75
19 Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK. J Clin Lab Immunol 1992 0.75
20 Tumor growth-promoting effect of immunosuppressive substance in mice. Cancer Invest 1989 0.75
21 Marked induction of HSP47, a collagen-binding stress protein, during solid tumor formation of ascitic Sarcoma 180 in vivo. In Vivo 1996 0.75
22 Inhibition of HSP47 during the transition from solid to ascitic form of Sarcoma 180 in vivo. In Vivo 1996 0.75
23 Effects of PSK on resistance to bacterial infection in splenectomized mice. Oncology 1988 0.75
24 Specific regulation of HSPs in human tumor cell lines by PSK. In Vivo 1997 0.75
25 Changes in electrophoretic mobility pattern of erythrocytes in patients with paroxysmal nocturnal hemoglobinuria. J Clin Lab Immunol 1987 0.75
26 Determination of an immunosuppressive substance in serum by latex particle electrophoresis. J Biochem Biophys Methods 1987 0.75
27 Involution of the thymus in tumor-bearing mice and its restoration by PSK. J Clin Lab Immunol 1983 0.75
28 Involution of the thymus in tumor-bearing mice and its restoration by PSK. II. Mechanism of the involution and its restoration. J Clin Lab Immunol 1987 0.75
29 [Restoration of immunologic responsiveness by PSK in tumor-bearing animals]. Gan To Kagaku Ryoho 1986 0.75
30 In vivo antineoplastic activity of mouse or human IgG conjugated with melphalan. In Vivo 1992 0.75
31 Effects of biological response modifiers with different modes of action used separately and together on immune responses in mice with syngeneic tumours. J Int Med Res 1992 0.75
32 Tumor growth promoting activity of an immunosuppressive substance and its modulation by protein-bound polysaccharide PSK. Immunol Lett 1987 0.75
33 Effect of PSK on the serum level of immunosuppressive substance in splenectomized rats. In Vivo 1992 0.75
34 Comparative study of alpha 1-acid glycoprotein molecular variants in ascitic fluid of cancer and non-cancer patients. Anticancer Res 1988 0.75
35 Cloning of sequences induced and suppressed by administration of PSK, antitumor protein-bound polysaccharide. Biochem Biophys Res Commun 1985 0.75
36 [Effects of krestin (PSK) on drug-metabolizing enzymes with special reference to the activation of FT-207]. Gan To Kagaku Ryoho 1986 0.75
37 Tumor and tissue distribution of 125I-labeled natural and antitumor antibodies in murine experimental tumor systems. Anticancer Res 1988 0.75
38 Effects of PSK, an antitumor protein-bound polysaccharide, on the surface charge of lymphocytes in X5563-bearing mice. J Clin Lab Immunol 1987 0.75
39 [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor]. Gan To Kagaku Ryoho 1986 0.75
40 Evaluation of anticancer drugs by lymphocyte electrophoresis. J Pharmacobiodyn 1986 0.75
41 Antitumor effects of 3-[p-(N,N-bis-(2'-chloroethyl)amino)-phenyl]-L- alanine conjugated with human immunoglobulin (K18). In Vivo 1991 0.75
42 Treatment with Krestin combined with mitomycin C, and effect on immune response. Oncology 1989 0.75
43 Purification and characterization of immunosuppressive (IS) substance obtained from ascitic fluids of patients with gastrointestinal cancer. Clin Biochem 1987 0.75
44 Effects of the protein-bound polysaccharide preparation, PSK on spontaneous breast cancer in mice. J Int Med Res 1988 0.75
45 [Involution of the thymus in tumor-bearing mice and its restoration by PSK (2)]. Gan To Kagaku Ryoho 1986 0.75
46 Production of antiserum against antitumor protein-bound polysaccharide preparation, PSK (Krestin) and its pharmacological application. Int J Immunopharmacol 1988 0.75
47 HSP47 as a possible marker for malignancy of tumors in vivo. In Vivo 1995 0.75